Customer Service: Write to info1@cyno.co.in
| Mechanism of Action | Roxithromycin is a semi synthetic long acting macrolide antibiotic. It binds to the 50S sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly formed peptide chain from the A site to the P site and fails to expose the A site .So that A site is unable to bind with the next aminoacyl t RNA complex. This leads to premature termination of amino acid chain and there by inhibits protein synthesis. |
| PharmacoKinetics | Absorption: Roxithromycin is absorbed after oral administration. Distribution: It is widely distributed in the body in protein bound form. Metabolism: small portion undergo metabolism. Excretion: It is primarily excreted through bile and also excreted through urine and breast milk |
| Onset of action | 1 – 2 hours |
| Duration of action | 8 – 12 hours |
| Adverse Effects | 1. Nausea 2. Vomiting 3. Diarrhoea 4. Epigastric pain 5. Fever 6. Rash 7. Urticaria 8. Increase in liver enzyme concentrations |
| Contraindications | 1. Hypersensitivity to Roxithromycin and other macrolide 2. Use of ergotamine type compound along with Roxithromycin |
| Special Precautions | 1. Hepatic dysfunction |
| Pregnancy | Contraindicated |
| Breastfeeding | Contraindicated |
| Old Age | May be used |
| Drug Interactions | Digoxin: Increases absorption. Midazolam: Increases its half-life. Terfenadine: Serum levels elevated leading to ventricular arrhythmias. Disopyramide: Displaced from its protein bound sites. |
| Indications | 1. Pneumonia 2. Tonsilitis 3. Pharyngitis 4. Bronchitis 5. ENT infection 6. Tetanus 7. Diphtheria 8. Sinusitis 9. Gonorrhea 10. Wound and burn infection 11. Skin and soft tissue infections 12. Pertusis 13. Urogenital infection |
| Dosage | Adult: 300 mg in two divided dose for 1 – 2 week Children: 4 – 8 mg/kg body weight/day in divided dose |
| Schedule | H |
| Storage | Store in a cool dark place. Keep away from heat and moisture. |
| Overdose | Give supportive measures and treatment |
No customer reviews for the moment.
It is a drug used for certain breast, lung and other cancers. Gefitinib is the first selective inhibitor of epidermal growth factor receptor’s (EGFR) tyrosine kinase domain. Thus Gefitinib is an EGFR inhibitor. The target protein (EGFR) is a family of receptors which includes Her 1(erb-B1), Her 2(erb-B2), and Her 3(erb-B3). EGFR is over expressed in the...
IMACY-100mgTyrosine kinase inhibitors (TKIs) have been approved for cancer treatment and numerous are under investigation. These drugs are rationally designed to target specific tyrosine kinases that are mutated and/or over-expressed in cancer tissues. Ninety-five percent of all chronic myelogenous leukemia (CML) was suggested to be the result of the...
IMACY-400mg n Tyrosine kinase inhibitors (TKIs) have been approved for cancer treatment and numerous are under investigation. These drugs are rationally designed to target specific tyrosine kinases that are mutated and/or over-expressed in cancer tissues.Ninety-five percent of all chronic myelogenous leukemia (CML) was suggested to be the result of the...
BORTENAT2MG INGREDIENT-Bortenat injection contain BortezomibINTRODUCTION-Bortenat 2mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma.
DASATINIB-20mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-50mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-70mg Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
CYNIVE-3(Ivermectin USP 3 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
CYNIVE-6(Ivermectin USP 6 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
CYNIVE-12(Ivermectin USP 12 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
FAVIPIRAVIR - 200 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
FAVIPIRAVIR - 400 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
FAVIPIRAVIR - 800 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
MOLNUPIRAVIR - 200 mgMolnupiravir, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.. Molnupiravir is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral action by introducing copying errors during viral RNA...
Pharmacology of Drug: Tenofovir Alafenamide (25mg)
Pirfenidone, a prescription medication, treats idiopathic pulmonary fibrosis by reducing lung scarring and swelling, improving breathing.
Sofosbuvir + Velpatasvir is a prescription antiviral combination used to treat chronic hepatitis C infection across all major genotypes by reducing viral replication and lowering viral load, ultimately helping the liver recover.